Start with the medical question
A good intake is more than a product request
Online peptide therapy intake should help a clinician understand the person, the goal, and the risk profile before deciding whether treatment is appropriate. Peptide12-listed options include compounded semaglutide, compounded tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, sermorelin, PT-141/bremelanotide, NAD+, glutathione, GHK-Cu topical foam, and low-dose oral methylene blue; each raises different screening questions.
- Write down what success would mean in practical terms, such as weight trend, appetite, fatigue, recovery, skin/scalp tolerance, sexual-health concerns, or medication access—not a guaranteed outcome.
- Include diagnoses, recent symptoms, allergies, pregnancy or fertility plans, surgery or anesthesia timing, and whether primary-care or specialist clinicians are already involved.
- If the goal is vague or symptoms are new, worsening, severe, or unexplained, the safer next step may be records, labs, urgent care, primary care, or specialist review rather than starting peptide therapy online.